## **Core Concept**
Methhemoglobinemia is a disorder characterized by an abnormal amount of methemoglobin, a form of hemoglobin, in the blood. Methemoglobin cannot effectively release oxygen to body tissues, leading to symptoms like cyanosis, shortness of breath, and fatigue. Certain local anesthetics (LAs) are known to induce this condition.

## **Why the Correct Answer is Right**
Prilocaine is a local anesthetic known to cause methemoglobinemia as a side effect. This occurs because prilocaine is metabolized into o-toluidine, which induces the formation of methemoglobin. The mechanism involves the oxidation of hemoglobin to methemoglobin, reducing the amount of hemoglobin available for oxygen transport.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Lidocaine is another local anesthetic but is not commonly associated with methemoglobinemia. It is metabolized differently than prilocaine and does not significantly induce methemoglobin formation.
* **Option B:** Bupivacaine is a long-acting local anesthetic. While it has various side effects, inducing methemoglobinemia is not commonly associated with its use.
* **Option C:** This option is not provided, but based on the correct answer being D, we can infer that options A, B, and C are incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that prilocaine is specifically known for its risk of causing methemoglobinemia, especially at higher doses. This side effect is less commonly associated with other local anesthetics. Clinicians should be cautious when using prilocaine, particularly in patients with conditions that might be exacerbated by methemoglobinemia.

## **Correct Answer:** D. Prilocaine